PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Drug side effects

cetirizine Side Effects

The reactions most often reported to the FDA for cetirizine (also sold as Zyrtec), with demographics, serious outcomes, and reporting trends.

Data updated 2026-05-15

72,729
FAERS reports

Data from the FDA Adverse Event Reporting System (FAERS), 2004 to 2025. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.

The most commonly reported side effects of cetirizine come from 72,729 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.

This page analyzes 72,729 reports to the FDA Adverse Event Reporting System (FAERS) for cetirizine (Zyrtec): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.

Total Reports

72,729

Reports Mentioning Death

7,810

10.7% of reports — not proof the medicine caused the death

Hospitalizations

22,963

31.6% of reports

Top Indication

Product Used For Unknown Indication

Most Reported Adverse Reactions

FATIGUE
12,861
PAIN
12,124
RASH
9,771
ABDOMINAL DISCOMFORT
9,317
ALOPECIA
9,237
RHEUMATOID ARTHRITIS
8,675
SYSTEMIC LUPUS ERYTHEMATOSUS
8,466
PEMPHIGUS
8,274
SWELLING
7,934
HYPERSENSITIVITY
7,746
GLOSSODYNIA
7,743
PRURITUS
7,514
ARTHRALGIA
7,475
HEADACHE
7,470
DYSPNOEA
7,156
JOINT SWELLING
6,995
INFUSION RELATED REACTION
6,954
HAND DEFORMITY
6,762

Who Reports Side Effects

Gender Distribution

Female 44,738 (71%)
Male 18,377 (29%)
Unknown 60

Age Distribution

0-17 4,644 (10%)
18-44 15,430 (32%)
45-64 14,527 (30%)
65-74 7,743 (16%)
75+ 5,859 (12%)

Reporting Trend by Year

2004 2025

Reactions in Death Reports

Top reactions reported in 7,810 reports where death was an outcome. These are voluntarily reported and do not establish causation.

Reaction Reports
FATIGUE 2,132
SYSTEMIC LUPUS ERYTHEMATOSUS 2,129
RASH 2,113
RHEUMATOID ARTHRITIS 2,110
GENERAL PHYSICAL HEALTH DETERIORATION 2,096
HYPERTENSION 2,093
INFUSION RELATED REACTION 2,089
HEPATIC ENZYME INCREASED 2,074
TYPE 2 DIABETES MELLITUS 2,070
GLOSSODYNIA 2,066
HAND DEFORMITY 2,037
DUODENAL ULCER PERFORATION 2,023
JOINT SWELLING 2,013
HELICOBACTER INFECTION 1,971
FIBROMYALGIA 1,969
HYPOAESTHESIA 1,966
SYNOVITIS 1,956
WOUND 1,954
PSORIATIC ARTHROPATHY 1,947

Reactions in Hospitalization Reports

Top reactions in 22,963 reports where hospitalization was an outcome.

Reaction Reports
FATIGUE 4,029
PAIN 3,617
DYSPNOEA 3,442
RASH 3,316
ABDOMINAL DISCOMFORT 3,230
PYREXIA 3,190
ARTHRALGIA 3,148
MALAISE 3,023
NAUSEA 2,989
DIARRHOEA 2,982
VOMITING 2,980
SWELLING 2,951
SYSTEMIC LUPUS ERYTHEMATOSUS 2,936
ALOPECIA 2,930
INFUSION RELATED REACTION 2,901
RHEUMATOID ARTHRITIS 2,886
HEADACHE 2,881
HYPERSENSITIVITY 2,808

Compare cetirizine vs azelastine →

What the FAERS Data Reveals About cetirizine Side Effects

The FDA Adverse Event Reporting System (FAERS) contains 72,729 voluntary reports linked to cetirizine and its brand equivalents (Zyrtec), spanning 2004 through 2025. Of those, 7,810 (10.7%) listed death as an outcome and 22,963 (31.6%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.

Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 71% were female and 29% male; age distribution skews toward 18-44, with 15,430 reports in that bracket. The single most reported reaction is fatigue with 12,861 submissions, followed by pain and rash.

How to read these numbers

FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.